Health Catalyst Grants RSUs to New CEO
News related to:Health Catalyst, Inc · 2 min read
SALT LAKE CITY, Sept. 14, 2026 /CourierPR/ -- Health Catalyst, Inc., a healthcare intelligence company, has announced the grant of restricted stock units (RSUs) to Simeon Kohl, who will assume the roles of Chief Executive Officer and President on September 14, 2026. The company's Compensation Committee awarded Kohl 2,747,385 RSUs under the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan, a plan designed to attract new talent to the company.
The RSU grant is structured to vest in two parts. One million nine hundred and fifteen thousand nine hundred and seventy-five (1,915,975) RSUs will vest on September 14, 2027, provided Kohl remains employed with the company. The remaining 831,410 RSUs will vest in eight equal quarterly installments, subject to Kohl’s continued employment with the company on each vesting date. The terms and conditions of the Inducement Plan and the RSU agreement cover the specifics of the grant.
Kohl’s appointment and the RSU grant are part of a broader strategy to enhance leadership and drive forward the company’s mission. Health Catalyst, Inc. aims to accelerate measurable improvement for health systems across cost, clinical, and consumer performance. The company’s deep domain expertise, AI-driven technology, and documented outcomes of $2.8 billion in performance improvements underscore its commitment to innovation and excellence.
Prior to his appointment, Kohl had already demonstrated his commitment to the company by purchasing 59,000 shares of Health Catalyst’s common stock through open market purchases. The weighted average price for these shares was $1.787188 per share, indicating his personal investment in the company’s success.
The RSU grant is in line with Nasdaq Listing Rule 5635(c)(4), which allows for the grant of equity awards to individuals who were not previously employees or directors of the company or its subsidiaries, as an inducement material to their entering into employment with the company. This aligns with Health Catalyst’s strategy to attract and retain top talent in the healthcare intelligence sector.
In summary, Health Catalyst, Inc. has taken a significant step in its leadership transition by granting Kohl a substantial RSU package, reflecting the company’s commitment to fostering growth and innovation.